Trial Details

RECRUITING
Basic Information
Clinical ID c888
Identifier NCT04424303
Trial Title Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Tofacitinib
Participant Information
Sponsor Pfizer
City Amiens
Country/Region France
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2020-12-04
Primary Completion Date 2026-06-30
Completion Date 2026-06-30